Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on asymmetric synthesis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel 3-step route for Salan ligands via CN102786466A. High yield, mild conditions, scalable process for asymmetric catalysis applications.
Novel asymmetric synthesis method for sitafloxacin intermediate ensures high optical purity and scalable production for global pharmaceutical supply chains seeking reliable partners.
Patent CN100473642C details a 4-step asymmetric synthesis of alpha-alkyl-isoserine with 98% ee. Offers cost-effective routes for pharmaceutical intermediates.
Patent CN103319526B enables high stereoselective synthesis of phosphorus chiral centers. Offers significant cost reduction and supply chain reliability for global pharmaceutical intermediate manufacturing.
Patent CN109180682A reveals a proline-based route for bicyclic NHC precursors, offering streamlined synthesis and enhanced supply chain reliability for global pharmaceutical intermediate manufacturing.
Patent CN102030690B details a novel two-step synthesis of axially chiral bissulfoxide ligands, offering high enantioselectivity and streamlined manufacturing for asymmetric catalysis applications.
Patent CN112824422B discloses a novel chiral ligand enabling high TON asymmetric hydrogenation for pharma intermediates with simplified synthesis.
Novel sulfonyl-pyrrolidine route for Brivaracetam. Reduces chiral separation costs and simplifies purification for scalable API manufacturing.
Patent CN106146448A reveals efficient synthesis of chiral alpha-fluoro beta-amino ketones. Discover cost reduction and supply chain advantages for pharmaceutical intermediates.
Novel synthesis route for high-purity pharmaceutical intermediate offering safety and scale-up advantages for global supply chains and cost reduction.
Patent CN103502208B reveals mild diamine synthesis avoiding Birch reduction. Enables cost reduction in pharmaceutical intermediate manufacturing and supply chain reliability.
Patent CN111018901A reveals a novel synthetic route for Zanamivir and Laninamivir intermediates, offering enhanced purity and cost-effective manufacturing solutions.
Novel patent CN103709092B offers simplified Mitiglinide Calcium synthesis. Enhances purity, reduces cost, ensures supply chain reliability for pharmaceutical manufacturers.
Patent CN101279954A details a one-step chiral oxazoline synthesis. This report analyzes cost reduction and supply chain reliability for high-purity pharmaceutical intermediates.
Patent CN105330608B details high-ee urazole synthesis. Discover cost-effective, scalable chiral ligand manufacturing for pharmaceutical applications.
Patent CN118666669A reveals efficient asymmetric synthesis for sitafloxacin intermediates. Achieve high purity and scalable production with reduced operational complexity.
Patent CN102675204B discloses efficient synthesis. Reduces cost and improves supply chain for high-purity pharmaceutical intermediates.
Patent CN105153009A reveals asymmetric bismaleimide for microelectronic packaging. Offers low viscosity, high thermal stability, and supply chain advantages.
Patent CN101952242A details a novel convergent synthesis for renin inhibitors like aliskiren, offering improved stereocontrol and scalability for pharmaceutical manufacturers.
Novel chiral synthesis route for Nebivolol HCl avoiding expensive raw materials. Ideal for reliable API intermediate suppliers seeking cost-effective scale-up.